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Clinical efficacyAbstract To have in-depth analysis of clinical ablation effect of noninvasive radiofrequency field-
induced hyperthermia on liver cancer cells, this paper collected liver cancer patients’ treatment
information from 10 hospitals during January 2010 and December 2011, from which 1050 cases
of patients were randomly selected as study object of observation group who underwent noninva-
sive radiofrequency field-induced hyperthermia treatment; in addition, 500 cases of liver cancer
patients were randomly selected as study object of control group who underwent clinical surgical
treatment. After treatment was completed, three years of return visit were done, survival rates of
the two groups of patients after 1 year, 2 years, and 3 years were compared, and clinical effects
of radiofrequency ablation of liver cancer were evaluated. Zoom results show that the two groups
are similar in terms of survival rate, and the difference is without statistical significance. 125 patients
in observation group had varying degrees of adverse reactions, while 253 patients in control group
had adverse reactions. There was difference between groups P< 0.05, with significant statistical
significance. It can be concluded that radiofrequency ablation of liver cancer is more secure. There-
fore, the results of this study fully demonstrate that liver cancer treatment with noninvasive
radiofrequency field-induced hyperthermia is with safety effect and satisfactory survival rate, thus
with relatively high clinical value in clinical practice.
 2016 Production and Hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Liver cancer, liver malignant tumor, can be divided into pri-
mary and secondary ones. Primary liver malignant tumor orig-
inates from liver epithelial or mesenchymal tissue, which
belongs to a serious malignant tumor (as shown in Fig. 1). Sec-
ondary liver cancer is relatively rare in comparison (Wu et al.,
2015a, 2015b). Secondary or metastatic liver cancer refers to
violations of the liver by malignant tumor that originates from
multiple body organs (as shown in Fig. 2). In recent years, with
Figure 3 Liver cancer treatment model with radiofrequency
ablation.
Figure 2 Secondary liver cancer.
Figure 1 Primary liver cancer.
330 K. Chen et al.the accelerating pace of life and the increasing bad habits in
life, incidence of liver cancer in countries has increased year
by year.
In clinical surgery, excision is usually adopted for liver can-
cer patients. But because of stealthiness of primary liver can-
cer, many patients in the early stages of hospitalization are
diagnosed as terminal stages of cancer. In this case, there is rel-
atively great risk for surgery, and only about 20% of patients
can receive surgical treatment. But the effect after treatment is
generally difficult to be satisfactory. Usually at six months
after the treatment, 30% of patients will have relapse of illness
(Wu et al., 2015a, 2015b; Xu et al., 2014; Han et al., 2015).
With the passage of time, the recurrence rate also rises, and
there are patients with metastasis and progression of the dis-
ease. It can be seen that effect of surgical treatment is difficult
to make people completely satisfied, and cannot provide strong
guarantee for health and safety of patients. In recent years,
with continuous development of medical concepts and medical
technology, radiofrequency ablation (RFA) therapy has
become one of important treatment means in comprehensive
treatment of liver cancer. Compared with surgical treatment,
non-invasive radiofrequency ablation treatment enjoys advan-
tages such as less trauma, safety and reliability, repeatability,
and low treatment costs (He et al., 2015; Zhang et al., 2015).Radiofrequency ablation is to insert radiofrequency elec-
trode into the tumor tissue under ultrasound or CT guidance.
Radiofrequency electrode emits radio frequency of 400 kHz,
polar molecules and ions in the tumor tissue have high-speed
motion vibration with the same rate as radiofrequency current,
generating frictional heat which is transmitted to adjacent tis-
sue, leading to internal temperature rise of tumor tissue, water
evaporation, drying, condensation in inner and exterior cells,
and thus aseptic necrosis, thereby killing tumor cells and
achieving therapeutic purposes. Thus, heat of radiofrequency
ablation derives from tissue surrounding electrode rather than
electrode itself (as shown in Fig. 3). Under normal circum-
stances, under 42 C, cells already have thermal damage. If
the temperature is increased to 45 C and lasts 3–50 h, cells will
have progressive degeneration. As the temperature rises, time
for irreversible cell damage is exponentially shorter. When
temperature is greater than 60 C, protein solidification occurs
instantaneously, resulting in cell death. Temperature over
100 C can cause boiling water within the tissue, evaporation
and until carbonization (August et al., 2016; Sang et al.,
2014). Fundamentally, lesion necrosis caused by radiofre-
quency ablation is different from classic ‘‘necrosis”. During
radiofrequency ablation, temperature of 80–110 C can make
tissue in vicinity of electrode directly freeze, which constitutes
the main body of radiofrequency ablation lesion. Life structure
affected by the heat energy, especially cytosolic enzyme pro-
tein, will be instantaneously solidified. This heat-induced struc-
tural variability and functional inactivation of the enzyme
protein determine that radiofrequency ablation is impossible
to have progressive enzymatic tissue damage or cell degrada-
tion as classic necrosis. Under the microscope, radiofrequency
ablation lesion section exhibits five tissue damage reaction
bands of temperature inclined curve from the center to the
outer periphery: A band – electrode needle tract, carbonization
or evaporation center caused by high heat production in the
periphery; B band and C band – tumors or tumor adjacent
to tissue paleness or reddish-brown coagulation necrosis
caused by moderate heat production; D band – sharp-edged
reddish or brown bleeding band caused by mild fever; and E
band – outer layer of edema caused by mild fever. Generally,
central region (A band) of radiofrequency ablation lesion
and two outer zones (D and E band) can be confirmed based
on characteristic change of tissue structure and cell compo-
nents. Intermediate solidification zone (B band and C band)
constitutes the main body of ablation lesions.
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ity of life of patients with this treatment method is done. The
result shows that radiofrequency ablation is with good effect
for treatment of liver cancer. See report below for specific
circumstances.
2. Materials and methods
2.1. General Information
Observation group: 1050 cases of patients, including 645 cases
of male patients, 405 cases of female patients; the patients were
aged between 45 and 76 years, with mean age at (58.97 ± 7.64)
years; the medical records of all patients are very complete,
who are not suitable for surgery or have no willingness due
to various reasons, and meet RAF indication. Maximum
diameter of liver lesion is 5 cm, and all patients accepted
RAF treatment. This group includes 599 cases of one lesion,
288 cases with two lesions and 163 cases with three lesions.
Child–Pugh classification results show that, there are 313 cases
in A grade, 392 cases in B grade, and 345 cases in C grade. All
cases were confirmed by serology, imaging or needle biopsy as
primary liver cancer. All patients were hospitalized for the first
time, untreated.
Control group: Among 500 cases of patients in the group,
the maximum diameter or diameter sum is 5 cm. There are
277 cases of male, 223 cases of female; the patients were aged
between 48 and 77 years, with mean age at (56.14 ± 8.12)
years. There are 289 cases with one lesion, 131 cases with
two lesions and 8 cases with three lesions. Child–Pugh classifi-
cation results show that, there are 281 cases in A grade, 156
cases in B grade and 63 cases in C grade. All the patients
received pathological diagnosis after operation.
2.2. Treatment methods
The control group takes conventional surgical treatment.
Intravenous anesthesia with tracheal intubation was per-
formed, and regular liver resection, hepatic segment resection
or tumor resection were chosen according to the tumor site.
Observation group patients were treated with radiofre-
quency ablation. Lide LDRF-120S radiofrequency therapy
instrument was used, with operating frequency at 400 KHz,
to be equipped with LDRF-120S multipolar RAF electrode
needle. Patients had preoperative fasting of 4–6 h, and took
appropriate position under B ultrasound guidance. Then
B-ultrasound detects liver cancer position. Choose the best
puncture point and mark, and apply routine disinfected towel.
After local infiltration anesthesia with 15% lidocaine and
under ultrasonic guidance, avoid larger intrahepatic vessels
and bile ducts, puncture multi-electrode needle to the tumor,
expand over security border of 1 cm of maximum tumor diam-
eter, and then start radiofrequency ablation (Qi et al., 2014;
Mellotte et al., 2015). In computer automatic mode, treatment
center temperature can reach 90–110e, with diameter of action
range reaching electrode expansion diameter. With the
increase in energy and extended treatment time, impedance
increases, computer control power automatically reduces,
and impedance rises to its highest before power drops to low-
est. Then after radiofrequency therapeutic equipment stops
working, recover sub-electrode and rotate about 30b. Opensub-electrodes and original diameter again, start ablation ther-
apy in automatic mode and 1 treatment is completed. During
treatment, use ultrasonic instrument to monitor change in echo
of treatment region, take B ultrasound super echo group size
for range estimate of therapeutic point, adjust electrode posi-
tion if necessary, and conduct multipoint treatment until the
entire tumor echo is enhanced. Finally, burn the needle to stop
bleeding and prevent needle tract implantation metastasis.
2.3. Comparison methods
Through medical records, laboratory, imaging results and
follow-up data collection, efficacy is evaluated. All patients
received liver color Doppler ultrasonography and AFP quan-
titative examination every month in the first 3 months after
treatment, and then reviewed liver color Doppler ultrasonog-
raphy and AFP quantitative examination every two months.
In case of suspicion of recurrence or local tumor progression,
conduct enhanced CT or ultrasound contrast examination,
and qualitative needle biopsy if necessary. In case of suspicion
of tumor residue or relatively great recurrence possibility, 1–2
times of preventive TACE treatment are recommended. For
patients diagnosed as recurrence or local tumor progression,
TACE or TAI therapy is conducted.
Regular therapy features outpatient review, supplemented
by telephone or SMS, etc. for follow-up to understand short-
term and long-term efficacy. Three years’ follow-up investiga-
tion was done for each patient, and survival rate at the first
year, second year, and third year of patients was compared.
Adverse reactions, disease metastasis and untoward effect of
the two groups of patients were recorded.
2.4. Statistical methods
SPSS19.0 statistical software was used for data analysis and
integration, with (n, %) to represent count data and chi-
square for test. When P< 0.05, it indicates statistical
significance.
3. Results
In comparison with survival rate of the two groups of patients,
there exists no statistical significance (P> 0.05), with observa-
tion group respectively 85.3%, 58.3%, 36.7%; control group
respectively 88%, 72%, 36%.
In observation group, 125 patients had varying degrees of
adverse reactions, while in control group, 253 patients had
adverse reactions. There was difference between groups
P< 0.05, with significant statistical significance.
4. Discussion and conclusion
The results of this study show that survival rate of patients
with surgical treatment and those with radiofrequency ablation
are basically the same, so both schemes have desirability. How-
ever, some patients may have certain fear of and resentment
toward surgical treatment in clinics, or have difficulty in bear-
ing the treatment cost. Clinical experience has shown that
radiofrequency ablation of liver cancer is a minimally invasive
treatment method with relatively good efficacy, especially for
332 K. Chen et al.5 cm liver cancer, which can achieve nearly the same therapeu-
tic effect as surgery. For primary liver cancer patients not suit-
able for or unwilling to receive surgical treatment,
radiofrequency ablation is an ideal treatment method.
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